Skip to content
← Full study record

NCT01352286 · OUTCOME

Peak Persistence of Modified T-cells in the Peripheral Blood

Redirected Auto T Cells for Advanced Myeloma · Source last updated 2019-12-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
copies per μg of DNA
Interval / dispersion
Full Range
Time frame
Post-infusion through Day 42

What was measured

Measurement of NY-ESO-1ᶜ²⁵⁹T cells in blood

Analysis population: Participants who received NYESO-1ᶜ²⁵⁹T following ASCT

Groups in this outcome

NYESO-1ᶜ²⁵⁹T Cells

Participants who received NYESO-1ᶜ²⁵⁹T following ASCT

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
NYESO-1ᶜ²⁵⁹T Cells25

Reported measurements

Source class 1
Values in copies per μg of DNA · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
NYESO-1ᶜ²⁵⁹T Cells143728.793Not reported7560.10284312.37Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        7560.10
        upper Limit
        284312.37
        value
        143728.793
denoms
  1. counts
    1. group Id
      OG000
      value
      25
    units
    Participants
description
Measurement of NY-ESO-1ᶜ²⁵⁹T cells in blood
dispersion Type
Full Range
groups
  1. description
    Participants who received NYESO-1ᶜ²⁵⁹T following ASCT
    id
    OG000
    title
    NYESO-1ᶜ²⁵⁹T Cells
param Type
MEAN
population Description
Participants who received NYESO-1ᶜ²⁵⁹T following ASCT
reporting Status
POSTED
time Frame
Post-infusion through Day 42
title
Peak Persistence of Modified T-cells in the Peripheral Blood
type
SECONDARY
unit Of Measure
copies per μg of DNA

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice